Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management

Abstract

Tick-borne encephalitis is an infection of central nervous system caused by tick-borne encephalitis virus transmitted to humans predominantly by tick bites. During the last few decades the incidence of the disease has been increasing and poses a growing health problem in almost all endemic European and Asian countries. Most cases occur during the highest period of tick activity, in Central Europe mainly from April to November. Tick-borne encephalitis is more common in adults than in children. Clinical spectrum of the disease ranges from mild meningitis to severe meningoencephalitis with or without paralysis. Rare clinical manifestations are an abortive form of the disease and a chronic progressive form. A post-encephalitic syndrome, causing long-lasting morbidity that often affects the quality of life develops in up to 50% of patients after acute tick-borne encephalitis. Clinical course and outcome vary by subtype of tick-borne encephalitis virus (the disease caused by the European subtype has milder course and better outcome than the disease caused by Siberian and Far-Easter subtypes), age of patients (increasing age is associated with less favorable outcome), and host genetic factors. Since clinical features and laboratory results of blood and cerebrospinal fluid are nonspecific, the diagnosis must be confirmed by microbiologic findings. The routine laboratory confirmation of the tick-borne encephalitis virus infection is based mainly on the detection of specific IgM and IgG antibodies in serum (and cerebrospinal fluid), usually by enzyme-linked immunosorbent assay. There is no specific antiviral treatment for tick-borne encephalitis. Vaccination can effectively prevent the disease and is indicated for persons living in or visiting tick-borne encephalitis endemic areas.

Epidemiology, clinical characteristics, diagnosis and vaccination of tick-borne encephalitis: an overview

“…To dël, áta riant cen tri nës ner vø sis te mos in fek ci jà, EE tu ri bû ti átrauk tas á di fe ren ci nae diag nos ti kà ne tik as me nims, gy ve nan tiems en de mi në se zo no se, bet ir kelia vu siems á di des nës ri zi kos re gio nus. Ri zi ka su sirg ti EE ke lio nës me tu pri klau so nuo se zo no, ap sau gos prie mo niø nau do ji mo si, ne pa ste ri zuo to pie no pro duk tø var to ji mo [2]. Nors li gos pre ven ci jai yra su kur tos efek ty vios ir sau gios vak ci nos, pas ta rai siais de ðimt me èiais ste bi mas di de lis serga mu mo pa di dë ji mas vi sa me pa sau ly je, ypaè Lie tu vo je Lie tu va yra en de mi nis er kiø pla ti na mø li gø re gio nas dël di de lio mið kin gu mo (treè da lá Lie tu vos te ri to ri jos su da ro mið kai), di dë jan èio ne dir ba mø þe miø plo to ir er këms veistis pa lan kiø kli ma to sà ly gø [5].…”

“…Pir mà jà EE fa zae daþ niausiai ly di gri pà pri me nan tys simp to mai: sub feb ri li tem pe ratû ra, gal vos skaus mai, nuo var gis, nu ga ros ir ga lû niø skaus mai, py ki ni mas [9]. Dau gu ma pa cien tø, ser gan èiø vie nos fa zës EE, pa ti ria kom pli ka ci jø, su si ju siø su cen tri ne ner vø sis te ma, -me nin gi tà, me nin go en ce fa li tà [2].…”

“…Ant ro sios kli ni ki nës fa zës me tu ran da ma leu ko cito zë (re tai di des në nei 15×10 9 /l), nor ma lus ar ba pa di dë jaes erit ro ci tø nu së di mo grei tis ir C re ak ty vu sis bal ty mas bei re tai nu sta to ma trom bo ci to pe ni ja [2]. Yra duo me nø, kad leu ko ci to zë yra daþ nes në jau nes niems pa cien tams.…”

“…Ðiuo me tu EE spe ci fi nio gy dy mo në ra, tai ko ma tik simp tomi në te ra pi ja [2]. Vo kie ti jo je at lik tos stu di jos me tu nu staty ta, kad ið 709 pa cien tø 12 % rei kë jo in ten sy vios te ra pijos, o 5 % -asis tuo ja mos ven ti lia ci jos [32].…”

An overview of tick-borne viral pathogens in the light of current literature

“…Hastalığın spesifik bir antiviral tedavisi yoktur. Kene kaynaklı ensefalitin endemik olduğu alanlarda yaşayanlar ya da o alanları ziyaret edenler için uygulanan aşılama ile hastalıktan korunmak olasıdır (26) .…”